LILRB2/CD85d/ILT4, His & Avi, Human
¥2200 | |
Z05598-100 | |
|
|
|
|
|
¥2200 | |
Z05598-100 | |
|
|
|
|
|
Species | Human | ||||||
Protein Construction |
|
||||||
Purity | > 95% as determined by BisTris PAGE | ||||||
Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||||
Expression System | HEK293 | ||||||
Theoretical Molecular Weight | 50.2 kDa | ||||||
Apparent Molecular Weight | Due to glycosylation, the protein migrates to 70-75 kDa based on Bis-Tris PAGE result. | ||||||
Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Serial dilutions of Anti-LILRB2 Antibody were added into LILRB2/CD85d/ILT4, His & Avi, Human, His Tag : Biotinylated HLA-G, His Tag binding reactioins. The half maximal inhibitiory concentration(IC50) is 75.3ng/ml. »
Immobilized LILRB2/CD85d/ILT4, His & Avi, Human, His Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Anti-LILRB2 Antibody, hFc Tag with the EC50 of 2.8ng/ml determined by ELISA. »
The purity of LILRB2/CD85d/ILT4, His & Avi, Human is greater than 95% as determined by SEC-HPLC. »
LILRB2/CD85d/ILT4, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Target Background | The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC). LILRB2 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. |
Synonyms | CD85d; ILT4; ILT-4; ILT4CD85d; LILRB2; LIR2; MIR10 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.